Skip to content
10-K

Annual Report

Q Therapeutics, Inc.

0001193125-14-144283

← back to feed
Filed
Apr 15, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Apr 15, 2014 29.36M sh
Capex FY 2013 · Dec 31, 2013 $431.27K
Capex FY 2013 · Dec 31, 2012 $2.36K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$17.35M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$2.12M
Sga Expense FY 2013 · Dec 31, 2013 $10.5M
Sga Expense FY 2013 · Dec 31, 2012 $1.46M
Rd Expense FY 2013 · Dec 31, 2013 $12.8M
Rd Expense FY 2013 · Dec 31, 2012 $2.09M
Net Income FY 2013 · Dec 31, 2013 −$23.88M
Net Income FY 2013 · Dec 31, 2012 −$3.06M
Net Income FY 2013 · Dec 31, 2011 −$2.6M
Net Income restated FY 2013 · Dec 31, 2010 −$864.85K
Net Income FY 2013 · Dec 31, 2009 −$755.73K
Net Income FY 2013 · Dec 31, 2008 −$13.21M
Operating Income FY 2013 · Dec 31, 2013 −$21.91M
Operating Income FY 2013 · Dec 31, 2012 −$3.06M
Gross Profit FY 2013 · Dec 31, 2013 $1.39M
Gross Profit FY 2013 · Dec 31, 2012 $485.03K
Cost Of Revenue FY 2013 · Dec 31, 2013 $4.8K
Revenue FY 2013 · Dec 31, 2013 $1.4M
Revenue FY 2013 · Dec 31, 2012 $485.03K
Current Liabilities FY 2013 · Dec 31, 2012 $1.3M
Current Assets FY 2013 · Dec 31, 2012 $1.28M
Total Assets FY 2013 · Dec 31, 2012 $1.31M
Cash And Equivalents FY 2013 · Dec 31, 2011 $2.74M
Stockholders Equity FY 2013 · Dec 31, 2011 $2.54M
Stockholders Equity FY 2013 · Dec 31, 2010 $209.76K
Stockholders Equity FY 2013 · Dec 31, 2009 −$281.45K
Stockholders Equity restated FY 2013 · Dec 31, 2008 $431.51K